RUBYnanomed highlighted as a startup to watch by cLAB Ventures
18 de August, 2020
HER2 Expression in Circulating Tumour Cells Isolated from Metastatic Breast Cancer Patients Using a Size-Based Microfluidic Device
3 de September, 2021
RUBYnanomed is part of the 2021 IGNITE Cohort
MassMEDIC, the Massachusetts Medical Device Industry Council, announced today the 2021 IGNITE Cohort, and RUBYnanomed was one of the awarded medtech startups.
Press release: follow the link
Related Articles
28 de September, 2022
Project acronym: BRIGHT Project name: Best-in-class canceR dIaGnostic cHip for patient sTratification. Project co-funded by the: European Innovation Council Project number: 190138134 Project Description:Through advanced microengineering […]
18 de August, 2020
cLAB Ventures launched a mentorship programme to accelerate the business development of startups innovating in the field of oncology, and RUBYnanomed was highlighted as a startup […]
MassMEDIC, the Massachusetts Medical Device Industry Council, announced today the 2021 IGNITE Cohort, and RUBYnanomed was one of the awarded medtech startups.
Press release: follow the link
